State-funded venture capital firm Connecticut Innovations has launched a $200m fund to stimulate the state’s bioscience sector.
Grants, equity investments and loans will all be available to bioscience-related ventures over the next ten years, following the passing of Senate Bill 842. The funds will be primarily be used to assist startups and university spin-outs cross the valley of death from the proof-of-concept stage and onwards, filling the gap that traditional venture funds steer away from.
The fund is…